Anticancer and Structure Activity Relationship of Non-Symmetrical Choline Kinase Inhibitors
Choline kinase inhibitors are an outstanding class of cytotoxic compounds useful for the treatment of different forms of cancer since aberrant choline metabolism is a feature of neoplastic cells. Here, we present the most in-depth structure-activity relationship studies of an interesting series of n...
Main Authors: | Santiago Schiaffino-Ortega, Elena Mariotto, Pilar María Luque-Navarro, María Kimatrai-Salvador, Pablo Rios-Marco, Ramon Hurtado-Guerrero, Carmen Marco, María Paz Carrasco-Jimenez, Giampietro Viola, Luisa Carlota López-Cara |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/9/1360 |
Similar Items
-
Biological Evaluation of New Thienopyridinium and Thienopyrimidinium Derivatives as Human Choline Kinase Inhibitors
by: Pilar María Luque-Navarro, et al.
Published: (2022-03-01) -
Anticancer Activity of the Choline Kinase Inhibitor PL48 Is Due to Selective Disruption of Choline Metabolism and Transport Systems in Cancer Cell Lines
by: Pablo García-Molina, et al.
Published: (2022-02-01) -
Choline supplements: An update
by: Urna Kansakar, et al.
Published: (2023-03-01) -
Effects of choline containing phospholipids on the neurovascular unit: A review
by: Proshanta Roy, et al.
Published: (2022-09-01) -
New Compounds with Bioisosteric Replacement of Classic Choline Kinase Inhibitors Show Potent Antiplasmodial Activity
by: Francisco José Aguilar-Troyano, et al.
Published: (2021-11-01)